健康资讯 Poseida Therapeutics(PSTX)：
Poseida Therapeutics(PSTX) 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-23-007030 Act: 34 Size: 17 MB 网页链接
Poseida Therapeutics(PSTX)：
Poseida Therapeutics(PSTX) 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-23-044175 Act: 34 Size: 71 MB 网页链接
Poseida Therapeutics(PSTX)：
Poseida Therapeutics(PSTX) 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-007007 Act: 34 Size: 437 KB 网页链接
Poseida Therapeutics(PSTX)：
Poseida Therapeutics(PSTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-014898 Size: 7 KB 网页链接
Poseida Therapeutics(PSTX)：
Poseida Therapeutics(PSTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-014906 Size: 9 KB 网页链接
Poseida Therapeutics(PSTX)：
Poseida Therapeutics(PSTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-014910 Size: 9 KB 网页链接
Poseida Therapeutics(PSTX)：
Poseida Therapeutics(PSTX) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-23-002017 Act: 34 Size: 8 KB 网页链接
Poseida Therapeutics(PSTX)：
Poseida Therapeutics(PSTX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-014908 Size: 9 KB 网页链接
